ASPIRE BIOPHARMA HOLDINGS, INC. Accounts Payable
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Accounts Payable of $972.11 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $972.11K.
- 2026-03-31: Accounts Payable, Current $857.92K.
- 2025-12-31: Accounts Payable, Current $1.01M.
- 2025-09-30: Accounts Payable, Current $1.06M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $972.11K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $857.92K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.01M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.35M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.43M 10-Q/A · filed 2025-08-13 |
| 2024-12-31 | $310.22K S-1/A · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |